Search results
FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall (NYSE:PFE)
Seeking Alpha· 4 days agoA panel of advisors unanimously agrees on the need for a monovalent COVID-19 shot targeting the JN.1...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via Yahoo News· 2 days agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 6 days agoShares of Novavax (NASDAQ:NVAX) soared 11% in morning trade, after the documents were released. The...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via AOL· 4 days ago(Reuters) -Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 6 days agoMSD released positive data from Phase II and III trials for its ADC therapy, sacituzumab...
FDA vaccine advisers vote unanimously in favor of updated COVID-19 shot for fall
WPTZ Burlington· 3 days agoThe Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday to...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 3 days agoThe vaccine is based on protein technology, which is appealing to people hesitant to use the newer...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 4 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
NHS England launches pioneering trials for world-first cancer vaccine
BioPharma-Reporter· 6 days agoTo date, thirty hospitals have joined NHS England's Cancer Vaccine Launch Pad, which aims to...
Novavax, With A 369% Gain, Tears Ahead Again On A Key FDA Move
Investor's Business Daily· 3 days agoIn a filing with the Securities and Exchange Commission, Novavax said the FDA said it completed its...